Marker Therapeutics Statistics
Total Valuation
MRKR has a market cap or net worth of $12.16 million. The enterprise value is $1.21 million.
Important Dates
The next estimated earnings date is Friday, November 14, 2025, after market close.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MRKR has 12.94 million shares outstanding. The number of shares has increased by 21.50% in one year.
| Current Share Class | 12.94M |
| Shares Outstanding | 12.94M |
| Shares Change (YoY) | +21.50% |
| Shares Change (QoQ) | +25.67% |
| Owned by Insiders (%) | 7.16% |
| Owned by Institutions (%) | 13.87% |
| Float | 10.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.81 |
| Forward PS | 7.91 |
| PB Ratio | 0.97 |
| P/TBV Ratio | 1.11 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.22 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.45
| Current Ratio | 3.45 |
| Quick Ratio | 2.84 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -144.68% and return on invested capital (ROIC) is -90.86%.
| Return on Equity (ROE) | -144.68% |
| Return on Assets (ROA) | -69.38% |
| Return on Invested Capital (ROIC) | -90.86% |
| Return on Capital Employed (ROCE) | -139.92% |
| Revenue Per Employee | $1.08M |
| Profits Per Employee | -$2.92M |
| Employee Count | 5 |
| Asset Turnover | 0.41 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MRKR has paid $49,953 in taxes.
| Income Tax | 49,953 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -75.35% in the last 52 weeks. The beta is 1.37, so MRKR's price volatility has been higher than the market average.
| Beta (5Y) | 1.37 |
| 52-Week Price Change | -75.35% |
| 50-Day Moving Average | 0.96 |
| 200-Day Moving Average | 1.31 |
| Relative Strength Index (RSI) | 37.02 |
| Average Volume (20 Days) | 196,929 |
Short Selling Information
The latest short interest is 285,739, so 2.21% of the outstanding shares have been sold short.
| Short Interest | 285,739 |
| Short Previous Month | 631,431 |
| Short % of Shares Out | 2.21% |
| Short % of Float | 2.75% |
| Short Ratio (days to cover) | 0.93 |
Income Statement
In the last 12 months, MRKR had revenue of $5.39 million and -$14.61 million in losses. Loss per share was -$1.35.
| Revenue | 5.39M |
| Gross Profit | -10.48M |
| Operating Income | -14.68M |
| Pretax Income | -14.56M |
| Net Income | -14.61M |
| EBITDA | n/a |
| EBIT | -14.68M |
| Loss Per Share | -$1.35 |
Full Income StatementBalance Sheet
The company has $10.46 million in cash and n/a in debt, giving a net cash position of $10.46 million or $0.81 per share.
| Cash & Cash Equivalents | 10.46M |
| Total Debt | n/a |
| Net Cash | 10.46M |
| Net Cash Per Share | $0.81 |
| Equity (Book Value) | 10.49M |
| Book Value Per Share | 0.93 |
| Working Capital | 10.49M |
Full Balance SheetCash Flow
| Operating Cash Flow | -10.88M |
| Capital Expenditures | n/a |
| Free Cash Flow | -10.88M |
| FCF Per Share | -$0.84 |
Full Cash Flow StatementMargins
Gross margin is -194.54%, with operating and profit margins of -272.41% and -271.11%.
| Gross Margin | -194.54% |
| Operating Margin | -272.41% |
| Pretax Margin | -270.18% |
| Profit Margin | -271.11% |
| EBITDA Margin | n/a |
| EBIT Margin | -272.41% |
| FCF Margin | n/a |
Dividends & Yields
MRKR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -21.50% |
| Shareholder Yield | -21.50% |
| Earnings Yield | -125.15% |
| FCF Yield | -93.25% |
Analyst Forecast
The average price target for MRKR is $10.25, which is 990.89% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.25 |
| Price Target Difference | 990.89% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 105.98% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 27, 2023. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jan 27, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
MRKR has an Altman Z-Score of -41.66 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -41.66 |
| Piotroski F-Score | 2 |
